Prevention of type 1 diabetes in NOD mice by genetic engineering of hematopoietic stem cells

Methods in Molecular Biology

Volumn 433, Issue , 2008, Pages 277-285

  Bagley, Jessamyn ^a   Tian, Chaorui ^a   Iacomini, John ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Bone marrow transplantation; MHC class II; T cells; Tolerance; Type 1 diabetes

Indexed keywords

MURINAE; MUS;

EID: 84934439105     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-59745-237-3_17     Document Type: Article

References (15)

1. McDevitt, H.O. (1998). The role of MHC class II molecules in susceptibility and resistance to autoimmunity. Curr Opin Immunol 10, 677-681.
2. Morel, P.A., J.S. Dorman, J.A. Todd, H.O. McDevitt, and M. Trucco. (1988). Aspartic acid at position 57 of the HLA-DQ beta chain protects against type I diabetes: a family study. Proc Natl Acad Sci USA 85, 8111-8115.
3. Nepom, G.T., and W.W. Kwok. (1998). Molecular basis for HLA-DQ associations with IDDM. Diabetes 47, 1177-1184.
4. Wicker, L.S., J.A. Todd, and L.B. Peterson. (1995). Genetic control of autoimmune diabetes in the NOD mouse. Annu Rev Immunol 13, 179-200.
5. Davies, J.L., Y. Kawaguchi, S.T. Bennett, J.B. Copeman, H.J. Cordell, L.E. Pritchard, P.W. Reed, S.C. Gough, S.C. Jenkins, S.M. Palmer, and et al. (1994). A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371, 130-136.
6. Mein, C.A., L. Esposito, M.G. Dunn, G.C. Johnson, A.E. Timms, J.V. Goy, A.N. Smith, L. Sebag-Montefiore, M.E. Merriman, A.J. Wilson, L.E. Pritchard, F. Cucca, A.H. Barnett, S.C. Bain, and J.A. Todd. (1998). A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nat Genet 19, 297-300.
7. Ilonen, J., M. Sjoroos, M. Knip, R. Veijola, O. Simell, H.K. Akerblom, P. Paschou, E. Bozas, B. Havarani, A. Malamitsi-Puchner, J. Thymelli, A. Vazeou, and C.S. Bartsocas. (2002). Estimation of genetic risk for type 1 diabetes. Am J Med Genet 115, 30-36.
8. Hattori, M., J.B. Buse, R.A. Jackson, L. Glimcher, M.E. Dorf, M. Minami, S. Makino, K. Moriwaki, H. Kuzuya, H. Imura, and et al. (1986). The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. Science 231, 733-735.
9. Lee, K.H., K.W. Wucherpfennig, and D.C. Wiley. (2001). Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat Immunol 2, 501-507.
10. Tian, C., J. Bagley, N. Cretin, N. Seth, K.W. Wucherpfennig, and J. Iacomini. (2004). Prevention of type 1 diabetes by gene therapy. J Clin Invest 114, 969-978.
11. Pages, J.C., and T. Bru. (2004). Toolbox for retrovectorologists. J Gene Med 6(Suppl 1), S67-82.
12. Bagley, J., and J. Iacomini. (2003). Gene therapy progress and prospects: gene therapy in organ transplantation. Gene Ther 10, 605-611.
13. Tian, C., J. Bagley, and J. Iacomini. (2005). Preventing autoimmune diabetes through gene therapy. Discovery Medicine 5, 186-190.
14. Dialynas, D.P., Z.S. Quan, K.A. Wall, A. Pierres, J. Quintans, M.R. Loken, M. Pierres, and F.W. Fitch. (1983). Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. J Immunol 131, 2445-2451.
15. Shen, F.-W. 1983. Monoclonal antibodies to mouse lymphocyte differentiation alloantigens. In Monoclonal Antibodies and T-Cell Hybridomas (U.H. G. J. Hammerling and J. F. Kearney, editors), Elsevier, Amsterdam, pp. 25-31.